We will plan an update of the following clinical areas:
Induction of labour in specific circumstances – suspected fetal macrosomia.
We found 182 new studies through surveillance of this guideline. New evidence that could affect recommendations was identified. Topic experts, including those who helped to develop the guideline, advised us about whether the following sections of the guideline should be updated:
What are the harms and benefits of induction of labour in women with suspected fetal macrosomia?
Topic experts highlighted new evidence on induction of labour for suspected fetal macrosomia. Topic experts advised that this review question should be updated to consider the risks and benefits of induction of labour for suspected fetal macrosomia.
Decision: This review question should be updated.
What are the harms and benefits of pharmacological-based methods in induction of labour?
What are the harms and benefits of mechanical methods in women undergoing induction of labour?
New evidence was identified on oxytocin with amniotomy, misoprostol and PGE2 which could impact on recommendations. Topic experts advised that these questions should be updated. Topic experts advised that the question on surgical methods should be rephrased to state mechanical methods to include all the interventions considered by the review question.
Decision: These review questions should be updated.
We also found new evidence that was not thought to have an effect on current recommendations. This evidence related to setting and timing and prevention and management of complications.
We did not find any new evidence related to information and decision-making or monitoring and pain relief.
After considering all the new evidence and views of topic experts, we decided that a partial update is necessary for this guideline.
See how we made the decision for further information.
This page was last updated: 09 January 2017